Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jakub Fichtl"'
Autor:
Josef Vodicka, Martin Pesta, Vlastimil Kulda, Katerina Houfkova, Bohuslava Vankova, Jakub Sebek, Martin Skala, Jakub Fichtl, Kristyna Prochazkova, Ondrej Topolcan
Publikováno v:
Cells, Vol 9, Iss 12, p 2611 (2020)
The aim of the study was to compare the prognostic significance of lymph node status of patients with lung cancer analyzed by three different methods: hematoxylin and eosin (H&E), immunohistochemistry of cytokeratin 19 (IHC CK19), and One-Step Nuclei
Externí odkaz:
https://doaj.org/article/99a2a9c308eb48029f881ee1a0fe785b
Autor:
Jakub Fichtl, Vladislav Třeška, Tomáš Skalický, Václav Liška, Josef Vodička, Petr Duras, Jakub Šebek, Kristýna Procházková
Publikováno v:
Onkologie. 14:287-290
Publikováno v:
European Surgery. 53:66-74
The aim of this study was to evaluate the short- and long-term results and risk factors of liver surgery in patients over the age of 70 following liver resection for colorectal liver metastases. A total of 650 patients with an average age of 63.8 ±
Autor:
Martin Svaton, Martin Skala, Monika Bludovská, Josef Vodicka, Jakub Šebek, Vladislav Treska, Bohuslava Vankova, Jakub Fichtl, Radek Kucera, Kristyna Prochazkova, Ondrej Topolcan, Ladislav Pecen
Publikováno v:
Anticancer research. 41(10)
AIM The aim of this study was to evaluate the utility of selected tumor markers for the detection of lung cancer recurrence during follow-up. PATIENTS AND METHODS The study group consisted of 109 patients and 109 healthy controls. The following bioma
Autor:
Jakub Fichtl, Bohuslava Vankova, Martin Skala, Kristyna Prochazkova, Vlastimil Kulda, Martin Pesta, Ondrej Topolcan, Katerina Houfkova, Josef Vodicka, Jakub Šebek
Publikováno v:
Cells
Volume 9
Issue 12
Cells, Vol 9, Iss 2611, p 2611 (2020)
Volume 9
Issue 12
Cells, Vol 9, Iss 2611, p 2611 (2020)
The aim of the study was to compare the prognostic significance of lymph node status of patients with lung cancer analyzed by three different methods: hematoxylin and eosin (H&
E), immunohistochemistry of cytokeratin 19 (IHC CK19), and One-St
E), immunohistochemistry of cytokeratin 19 (IHC CK19), and One-St
Autor:
Stanislav Kormunda, Jakub Fichtl, Martin Skala, Ondřej Topolčan, Jakub Šebek, Martin Svatoň, Vladislav Třeška, Bohuslava Vaňková, Kristýna Procházková, Radek Kucera, Josef Vodicka
Publikováno v:
Anticancer research. 40(12)
Background/aim The lungs are the second most common site of cancer dissemination. The aim of this study was to analyze a cohort of patients operated for pulmonary metastases from colorectal carcinoma over a period of 18 years. Patients and methods In
Autor:
Vladislav, Treska, Jan, Bruha, Vaclav, Liska, Jakub, Fichtl, Kristyna, Prochazkova, Tereza, Petrakova, Petr, Hosek
Publikováno v:
In Vivo
Background/Aim: Portal vein embolization (PVE) with autologous stem cells application (aHSC) is a method for future liver remnant volume (FLRV) increase. The aim of the study was to evaluate the positivite and negativite aspects of the method in clin
Autor:
Vaclav Liska, Skalicky T, Radek Kucera, Jiri Ferda, Daniel Lysák, Jakub Fichtl, Inka Treskova, Jan Bruha, Vladislav Treska, Jaroslav Ludvik, Ondrej Topolcan
Publikováno v:
Anticancer Research. 38:5531-5537
BACKGROUND Portal vein embolization (PVE) and PVE with autologous mesenchymal stem cell application (PVE-MSC) increases future liver remnant volume (FLRV). The aim of this study was to compare both methods from the aspect of FLRV growth, progression
Autor:
Jan Baxa, Jiří Ferda, Petr Duras, Vladislav Třeška, Daniel Lysák, Jakub Fichtl, Táňa Matoušková, Jaroslav Ludvik, Brůha J
Publikováno v:
CardioVascular and Interventional Radiology. 40:690-696
This study aimed to evaluate the progress of future liver remnant volume (FLRV) in patients with liver metastases after portal vein embolization (PVE) with the application of hematopoietic stem cells (HSCs) and compare it with a patients control grou
Autor:
Milan Hora, Sabine D. Brookman May, Petr Hosek, Vladislav Třeška, Kristýna Procházková, Ondřej Hes, Jakub Fichtl, Josef Vodicka, Jakub Šebek, Gabriela Krakorova, Milena Roušarová
Publikováno v:
Urologia internationalis. 103(3)
Introduction: Clear cell renal cell carcinoma (ccRCC) is the most common kidney tumor. If feasible, metastasectomy is preferably indicated in metastatic disease. Objective: The aim of this study was to determine the outcome of patients after pulmonar